TelyRx triples Clearwater headquarters after reaching 1M prescriptions
TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) announced an expansion of its Clearwater, Fla., headquarters and pharmacy operations, more than tripling the company's overall footprint, according to a press release dated July 14, 2026.
The expansion follows what the company reported as a milestone of one million prescriptions filled and first-quarter revenue growth of 180% year-over-year.
TelyRx operates a digital pharmacy platform that connects patients with independent, state-licensed healthcare providers, offering access to more than 450 FDA-approved medications across 48 U.S. states and territories.
The company said it is seeking to hire across pharmacy, clinical, and fulfillment roles to support operations at the expanded facility.
"Filling one million prescriptions is a milestone worth celebrating, but what matters most is how many customers come back for a second, third or tenth order," said Vanessa Slowey, President and Chief Executive Officer of TelyRx. "Their repeat orders tell us that fast, affordable access to everyday medications is exactly what they've been waiting for."
You May Also Be Interested In
- Abbott settles preterm formula NEC lawsuits for $670 million
- GitLab releases version 19.3 with AI gateway and secrets tools
- Provident Financial prices $175M subordinated notes at 6.50%
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share